Select a State

Global health R&D delivers for Ohio

US government investment in global health R&D has delivered

$165.5 million
to Ohio research institutions
2,200+ new jobs
for Ohio

Neglected diseases in Ohio

Chikungunya cases
52
Dengue cases
59
HIV diagnoses
9,046
Malaria cases
285
Tuberculosis cases
1,464
West Nile cases
251
Zika cases
86

Ohio's top USG-funded global health R&D institutions

Case Western University
$99.6 million
Ohio State University
$36.4 million
Cincinnati Children’s Hospital Medical Center
$14.9 million
University of Toledo
$6.5 million
Cleveland Clinic Lerner College of Medicine
$3.3 million
Cleveland State University
$3.3 million
Ohio University
$1.5 million
University of Cincinnati
$1.3 million
Wright State University
$1 million
Nationwide Children’s Hospital
$685 thousand

Ohio industry in global health R&D

AstraZeneca
Location(s):
West Chester
Biosortia Pharma
Location(s):
Dublin
Charles River Laboratories
Location(s):
Ashland, Cleveland, Spencerville
Clinical Research Management
Location(s):
Hinkley
Guild Associates
Location(s):
Dublin
Metallopharm
Location(s):
Powell
Quidel
Location(s):
Athens

Ohio's top areas of global health R&D by USG funding

10.4%
HIV/AIDS
15.0%
Malaria
37.8%
Tuberculosis
6.3%
Diarrheal diseases
6.6%
Salmonella infections
16.3%
Neglected tropical diseases
Helminths
Kinetoplastids
7.6%
Other
Bacteria pneumonia & meningitis
Cryptococcal meningitis
Non-allocable

Global health R&D at work in Ohio

Cincinnati Children’s Hospital Medical Center led early stage clinical trials of two Shigella vaccine candidates. Worldwide, Shigella causes more than 150 million cases of severe diarrhea and dysentery annually, including 500,000 cases in the United States, and kills more than 1 million people each year, most of whom are young children in low-income countries. Antibiotics are the standard treatment, but drug-resistant strains are emerging, and no vaccine is yet available.

Footnotes